Medtronic begins aDBS therapy trial with Parkinson’s disease patients
The ADAPT-PD trial will evaluate the safety and efficacy of aDBS therapy in patients with Parkinson's disease
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
15 Jan 21
The ADAPT-PD trial will evaluate the safety and efficacy of aDBS therapy in patients with Parkinson's disease
14 Jan 21
Several medical devices approved over the past few months show promise in their ability to treat the causes…
13 Jan 21
Texas A&M researchers made a device that uses light to suppress hunger, but whether it could become a…
12 Jan 21
The ProTrap Luma includes a collection vessel with magnifying window and glow stick for enhanced visualization
A “surge period” in endoscopic haemostasis devices sales and procedures won't be enough to completely offset revenues lost…
08 Jan 21
Ehave a digital therapeutics and developer of KetaDASH, a home delivery platform for patients prescribed with Ketamine infusions
07 Jan 21
Used for the management of symptoms of movement disorders such as Parkinson's disease, Percept PC Neurostimulator with BrainSense…
22 Dec 20
Ingenion will use the proceeds over the next six months to gain a CE Mark for its CymActive…
21 Dec 20
The US FDA approved OPRA Implant System after the review of the device under its Premarket Approval (PMA)…
16 Dec 20
Neovasc is a specialty medical device company that develops, manufactures and markets products for the cardiovascular marketplace